NEVVI Medicare utilization intelligence

← back

VERA AGUILERA, JESUSM.D. NPI 1265872196 Clinician

Hematology-Oncology · DULUTH, MN

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 16 years since medical school (class of 2010, self-reported to CMS)
Location DULUTH, MN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 59 codes billed · 65,465 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MINNESOTA ONCOLOGY HEMATOLOGY PA
2024–2026
THE DULUTH CLINIC LTD
2020–2023
MAYO CLINIC
2019

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2019-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0185 Injection, aprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9299 Injection, nivolumab, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0897 Injection, denosumab, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J2469 Injection, palonosetron hcl, 25 mcg
J1626 Injection, granisetron hydrochloride, 100 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96375 Injection of additional new drug or substance into vein
80053 Blood test, comprehensive group of blood chemicals
J0640 Injection, leucovorin calcium, per 50 mg
36415 Insertion of needle into vein for collection of blood sample
J9045 Injection, carboplatin, 50 mg
96413 Administration of chemotherapy into vein, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J9190 Injection, fluorouracil, 500 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
96372 Injection of drug or substance under skin or into muscle
82784 Gammaglobulin (immune system protein) measurement
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J3489 Injection, zoledronic acid, 1 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
82728 Ferritin (blood protein) level
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
83540 Iron level
83550 Iron binding capacity
84443 Blood test, thyroid stimulating hormone (tsh)
J1200 Injection, diphenhydramine hcl, up to 50 mg
83521 Measurement of immunoglobulin light chains
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96415 Administration of chemotherapy into vein, each additional hour
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
85046 Red blood count automated, with additional calculations
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
84165 Protein measurement, serum
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96361 Infusion into a vein for hydration, each additional hour
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J7030 Infusion, normal saline solution , 1000 cc
J3490 Unclassified drugs
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
71260 Ct scan of chest with contrast
83615 Lactate dehydrogenase (enzyme) level
74177 Ct scan of abdomen and pelvis with contrast
84153 Psa (prostate specific antigen) measurement, total
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
82607 Cyanocobalamin (vitamin b-12) level
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.